About the GSK Study Register
The GlaxoSmithKline (GSK) Study Register provides an easily accessible repository of data and information from GSK studies, supplementing communication in journals, at scientific meetings, in
letters to healthcare professionals, and in approved prescribing information. We aim to publish our clinical research as papers in the scientific literature. We provide publication citations with
studies on this register. Where there is no citation the study has not yet been published. For a small number of studies a publication is not being progressed. This may be because it has been
rejected by journals or because it is unlikely to be published by journals - for example where a study is terminated early with little or no data.
It is important to emphasise that approved prescribing information must continue to guide appropriate use of GSK medicines. This information may vary from country to country. Before prescribing any product mentioned in the Register, Healthcare Professionals should consult prescribing information approved in their country.
Use of the data and information contained in Protocol Summaries, Scientific Results Summaries, Protocols, and Clinical Study Reports on this Register is unrestricted, provided that it may not be used in applications by others for regulatory approval of a product. While not required, when using this data, we ask that proper credit or attribution of GSK as the source of the data be given. GSK disclaims liability for all uses of the data by users of this Register, to the fullest extent permitted by applicable law. No trademark, patent, or regulatory/data exclusivity rights held by GSK are waived, licensed or otherwise affected.
- Protocol Summaries
- Scientific Results Summaries
- Plain Language Results Summaries
- Full Protocols
- Analysis Plans
- Clinical Study Reports
- Clinical Publications
- Patient Level Data for Researchers
- Regulatory Overview Documents
- Pre-Clinical Publications
GSK Alliance Companies
GSK has many alliances with other pharmaceutical companies. As part of these alliances, GSK may not have been the regulatory sponsor of all clinical studies for a product and therefore the results of such studies may not appear on this register. Please see other public registries such as www.ClinicalTrials.gov or EU Clinical Trials Register for any study disclosures from our alliance companies.
For more information on this register please email GSKClinicalSupportHD@gsk.com
GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.
IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).
This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.
EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.